Clonidine hydrochloride
-
Clonidine hydrochloride
structure -
-
CAS No:
4205-91-8
-
Formula:
C9H9Cl2N3.ClH
-
Chemical Name:
Clonidine hydrochloride
-
Synonyms:
1H-Imidazol-2-amine,N-(2,6-dichlorophenyl)-4,5-dihydro-,hydrochloride (1:1);2-Imidazoline,2-(2,6-dichloroanilino)-,monohydrochloride;1H-Imidazol-2-amine,N-(2,6-dichlorophenyl)-4,5-dihydro-,monohydrochloride;Catapressan;Catapres;Clonidine hydrochloride;ST 155;2-[(2,6-Dichlorophenyl)amino]-2-imidazoline monohydrochloride;Haemiton;Chlophazolin;2-[(2,6-Dichlorophenyl)amino]-2-imidazoline hydrochloride;Katapresan;Clonidine chloride;Atensina;Capresin;DCAI;Hemiton;Normopresan;Clonidine monohydrochloride;Clofelin;Isoglaucon;2-(2,6-Dichloroanilino)-2-imidazoline hydrochloride;Neuclon;Clopheline;KAPVAY;Dichloranilino imidazolin;7555-15-9;57665-50-6;64638-22-8;66009-47-0;66073-52-7;73121-65-0
-
Categories:
Active Pharmaceutical Ingredients > Circulatory System Drugs
-
CAS No:
Description
Clonidine hydrochloride is an agonist of α2-adrenoceptor and potent antihypertensive agent.
Clonidine hydrochloride is a dichlorobenzene.|Clonidine Hydrochloride is the hydrochloride salt form of clonidine, an imidazoline derivate and centrally-acting alpha-adrenergic agonist as well as antagonist with antihypertensive activity. Clonidine hydrochloride binds to and stimulates central alpha-2 adrenergic receptors, thereby decreasing sympathetic outflow to the heart, kidneys, and peripheral vasculature. The reduction in sympathetic outflow, leads to decreased peripheral vascular resistance, decreased blood pressure, and decreased heart rate.|An imidazoline sympatholytic agent that stimulates ALPHA-2 ADRENERGIC RECEPTORS and central IMIDAZOLINE RECEPTORS. It is commonly used in the management of HYPERTENSION.
Clonidine hydrochloride Basic Attributes
266.55
264.994019
224-121-5
W76I6XXF06
756699
DTXSID8044670
C47979
2933290090
Characteristics
36.4
white
305 °C
319.3°C at 760 mmHg
146.9ºC
soluble in water (50 mg/ml), DMSO (75 mM), methanol, chloroform (slightly), and dehydrated alcohol.
2-8°C
Oral-Rat LD50: 126 mg/kg; Oral-Mouse LD50: 139 mg/kg
Flammable; burning produces toxic chloride and nitrogen oxide fumes
143.3 Ų [M+H]+ [CCS Type: TW, Method: calibrated with polyalanine and drug standards]
Safety Information
III
6.1(b)
UN 2811 6.1/PG 1
3
25-26
22-26-28-36/37/39-45
NJ2490000
T+
Storehouse ventilated at low temperature and dry; stored separately from oxidants, alkalis, food additives
Missing Phrase - N15.00950417-P260-P304 + P340 + P310-P403 + P233
H301-H330
|Danger|H301 (100%): Toxic if swallowed [Danger Acute toxicity, oral]|P260, P264, P270, P271, P284, P301+P310, P304+P340, P310, P320, P321, P330, P403+P233, P405, and P501|Aggregated GHS information provided by 49 companies from 4 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies.
Drug Information
Sedation
Compounds that bind to and activate ADRENERGIC ALPHA-2 RECEPTORS. (See all compounds classified as Adrenergic alpha-2 Receptor Agonists.)|Drugs that inhibit the actions of the sympathetic nervous system by any mechanism. The most common of these are the ADRENERGIC ANTAGONISTS and drugs that deplete norepinephrine or reduce the release of transmitters from adrenergic postganglionic terminals (see ADRENERGIC AGENTS). Drugs that act in the central nervous system to reduce sympathetic activity (e.g., centrally acting alpha-2 adrenergic agonists, see ADRENERGIC ALPHA-AGONISTS) are included here. (See all compounds classified as Sympatholytics.)|Compounds capable of relieving pain without the loss of CONSCIOUSNESS. (See all compounds classified as Analgesics.)|Drugs used in the treatment of acute or chronic vascular HYPERTENSION regardless of pharmacological mechanism. Among the antihypertensive agents are DIURETICS; (especially DIURETICS, THIAZIDE); ADRENERGIC BETA-ANTAGONISTS; ADRENERGIC ALPHA-ANTAGONISTS; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; CALCIUM CHANNEL BLOCKERS; GANGLIONIC BLOCKERS; and VASODILATOR AGENTS. (See all compounds classified as Antihypertensive Agents.)
Catapres
Clonidine hydrochloride Use and Manufacturing
To a 500 ml reaction flask was added 300 ml of ethanol and 66 g of intermediate 2, and the mixture was heated to reflux with stirring. Remove heat while insolubleAdd 35g of hydrogen chloride-ethanol solution to the filtrate, add dropwise, reflux and stir for 50min, then cool to room temperature naturally, then cool to 0 °C-5 °C and stir and crystallize for 3h, suction filtration, filter cake with a small amount of ethanol to wash, that is Crude hydrochloride hydrochloride.The solid wet product obtained in the above step was added to a 1 L reaction flask, 300 ml of ethyl acetate was added, and the mixture was stirred at room temperature for 1.5 h.After filtration, the cake was washed with a small amount of ethyl acetate and dried to give 51.2 g of white solid.
In shaving soaps.
Human drugs -> Rare disease (orphan)|Human Drugs -> EU pediatric investigation plans|Human Drugs -> FDA Approved Drug Products with Therapeutic Equivalence Evaluations (Orange Book) -> Active Ingredients
Computed Properties
Molecular Weight:266.6
Hydrogen Bond Donor Count:3
Hydrogen Bond Acceptor Count:1
Rotatable Bond Count:2
Exact Mass:264.994030
Monoisotopic Mass:264.994030
Topological Polar Surface Area:36.4
Heavy Atom Count:15
Complexity:222
Covalently-Bonded Unit Count:2
Compound Is Canonicalized:Yes
Drug Function and Efficacy
It stimulates the alpha adrenal receptors in the brainstem, reduces the outflow of sympathetic nerves from the central nervous system, and reduces peripheral resistance, renal vascular resistance, heart rate, and blood pressure. It takes effect relatively quickly, and blood pressure reduction begins within 30-60 minutes after oral administration, and the maximum effect is achieved within 2-4 hours. Renal blood flow and glomerular filtration rate remain basically unchanged, and upright symptoms are mild and rare. Acute studies have shown that cardiac output is appropriately reduced (15%-20%) in the supine position, and peripheral resistance remains unchanged; cardiac output is slightly reduced when tilted at 45°, and peripheral resistance is reduced. During long-term treatment, cardiac output tends to return to control values, while peripheral resistance remains reduced.
Registered Holders
-
ENALTEC LABS PRIVATE LTD
Active
United States
-
ALEMBIC PHARMACEUTICALS LTD
Active
United States
-
SOCIETA ITALIANA MEDICINALI SCANDICCI SIMS SRL
Active
United States
Recommended Suppliers of Clonidine hydrochloride
-
CN
5 YRS
Business licensedTrader Supplier of Pharmaceuticals,Peptide,Cosmetics,Nutritional SupplementsInquiryCAS No.: 4205-91-8Grade: Pharmaceutical GradeContent: 99.5% -
CN
1 YR
Business licensedTrader Supplier of pregabalin,Tirzepatide,Retatrutide,Food Additives,semaglutide,Cosmetics material,Food additive,Chemical intermediate,Active pharmaceutical ingredientsInquiryCAS No.: 4205-91-8Grade: USP / EP / BP / JP GradeContent: 99% -
CN
5 YRS
Business licensed Certified factoryManufactory Supplier of Herb Extracts,Cosmetic raw materails,APIInquiryCAS No.: 4205-91-8Content: 0.00% -
CN
2 YRS
Business licensedTrader Supplier of ghk cuInquiryCAS No.: 4205-91-8Grade: Pesticide GradeContent: 99%
Learn More Other Chemicals
-
4H-1-Benzopyran-4-one, 2-[4-[3-(dibutylamino)propoxy]-3,5-dimethylbenzoyl]-, hydrochloride (1:1)
67652-33-9
-
Cyclopropanecarboxylic acid, 1-amino-2-ethenyl-, ethyl ester, hydrochloride (9CI)
681807-60-3
-
CYCLOPENTYL-(3,4,5-TRIMETHOXY-BENZYL)-AMINE HYDROCHLORIDE
1052525-88-8
-
2-Cyclopropylbenzenemethanamine hydrochloride Formula
118184-64-8
-
Des[4-(2-cycloproylMethoxy)] Betaxolol Hydrochloride Formula
464877-45-0
-
Ethanamine, 2-(decylthio)-, hydrochloride (1:1) Formula
36362-09-1
-
4,7-Dichloro-2-propylquinoline hydrochloride Structure
1204812-22-5
-
6,7-Dichloro-4-hydrazino-2-methylquinoline hydrochloride Structure
1170377-12-4
-
What is 2,8-Diazaspiro[4.5]decan-1-one, 2-[(4-bromophenyl)methyl]-, hydrochloride (1:1)
832710-56-2
-
What is 6,7-Dichloro-4-hydrazinoquinoline hydrochloride
1171843-02-9